A multicenter, open label, randomized phase ii study of mln9708 plus oral dexamethasone or plus oral cyclophosphamide and dexamethasone or plus bendamustine and dexamethasone or plus oral cyclophosphamide, thalidomide and dexamethasone followed by maintenance with mln9708 or placebo treatment in newly diagnosed elderly multiple myeloma patients

Study map

Overview / Summary

Study details

Patient eligibility criteria

  • Newly diagnosed MM based on standard CRAB criteria.
  • Age ≥ 65 years old or younger not eligible for transplantation


No publications connected to this trial at the moment